Ipsen lifts outlook as Q3 sales rise 5 pct
PARIS Oct 29 (Reuters) - French drugmaker Ipsen raised its outlook for 2012 as it reported a 5 percent increase in third-quarter revenue, driven by sales of drugs prescribed by specialist doctors.
Sales rose to 295 million euros ($382 million) in the three months to Sept. 30 from 281 million a year earlier, Ipsen said on Monday. ($1 = 0.7733 euros) (Reporting by Elena Berton)
- Insight: How U.S. spying cost Boeing multibillion-dollar jet contract
- Exclusive: Secret contract tied NSA and security industry pioneer |
- With Fed out of the way, what's next on Wall Street?
- Insight: For Chinese farmers, a rare welcome in Russia's Far East
- Analysis: Lost Brazil order raises threat to Boeing fighter jets